Humans and AI will soon design highly developable, epitope-specific antibodies

Our Observations

1. AI companies either scale with compute or don't scale at all
2. Proteins are dynamic structures, but existing data is biased toward static structures
3. Antibody models ought to optimize the underlying biophysics else fail to generalize outside the narrow slice of observed antibody space